HIV/AIDS and Florida Prevention Programs
Target Audience: Pharmacist, Pharmacy Tech
Course Overview
The human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV can significantly depress immune system function, leading progressively to AIDS. Antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV-1 infection and AIDS, enabling HIV-infected individuals to live longer and have an improved quality of life. Advancements in ART have allowed many patients with HIV to achieve viral suppression. Nevertheless, HIV and AIDS are still serious health problems requiring federal and state resources. The Omnibus AIDS Act, Florida, as amended, guides and mandates Florida health care clinicians in the areas of screening, diagnosing, and reporting HIV/AIDS under A Brief Legal Guide For Health Care Professionals. Florida law reflects existing recommendations by the Centers for Disease Control and Prevention and other national organizations concerned with HIV testing and methods to avoid disease transmission through voluntary testing.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Meet the continuing education requirements of the Florida Administrative Code, Rule 64B16-26.103(1)(a)
- Identify how HIV/AIDS is transmitted
- Identify methods of prevention and precaution for HIV/AIDS transmission
- Describe the types of co-occurring disorders that may be seen in patients diagnosed with HIV/AIDS
- Describe the State of Florida law on HIV/AIDS and its impact on testing, including the offering of HIV testing to pregnant women
- Describe the State of Florida law on reporting HIV/AIDS and partner notification
Faculty
- Introduction
- Defining HIV and AIDS
- Stages of HIV Infection
- Epidemiology of HIV and AIDS
- HIV Transmission
- Prevention of HIV Transmission
- Non-occupational Prevention Strategies
- Occupational Prevention Strategies
- Post-exposure Prophylaxis for All HIV Exposures
- PEPline Hotline: call 1-888-448-4911
- Risk of Needlestick Injuries
- HIV Screening and Testing
- Home Screening Tests
- Florida Omnibus AIDS Act
- Confidentiality
- Patient Rights
- Myths About HIV and AIDS
- Clinical Management
- Pre-Exposure Prophylaxis (PrEP)
- Post-Exposure and Brief Overview of Antiretrovirals
- Drug-drug Interactions
- AIDS and Concomitant Disorders
- Tuberculosis and Other Pulmonary Diseases
- Summary
- Disclosures
From July 1, 2026 through July 1, 2027, participants must:
- Read the "learning objectives" and "author and planning team disclosures"
- Study the section entitled "educational activity"
- Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)
Credit for this course will be automatically uploaded to CPE Monitor®.
Faculty Planner Disclosure
The following individuals were involved in planning, developing, and/or authoring this activity: Steven Malen, PharmD, MBA; and Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships related to the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosure
The information provided in this course is general in nature, and it is designed solely to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant's professional practice, including but not limited to patient assessment, diagnosis, treatment, and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals must consult their employer, healthcare facility, hospital, or other organization for guidelines, protocols, and procedures to follow. The information provided in this course does not replace those guidelines, protocols, and procedures, but is for academic purposes only, and this course's limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses is constantly changing. Any person taking this course understands that such a person must make an independent review of medication information before any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only, and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course or course material.
Please ensure the device you plan to use meets these requirements:
- Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
Accreditation
In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PTCB Recognition
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".